As of April 16, 2025, Exact Sciences (EXAS) has a market cap of $8.11 billion USD. According to our data, Exact Sciences is ranked No.1870 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $8.11 B |
-22.00%
|
Dec 31, 2024 | $10.40 B |
-24.05%
|
Dec 29, 2023 | $13.69 B |
49.42%
|
Dec 30, 2022 | $9.16 B |
-36.39%
|
Dec 31, 2021 | $14.40 B |
-41.26%
|
Dec 31, 2020 | $24.52 B |
43.26%
|
Dec 31, 2019 | $17.12 B |
46.56%
|
Dec 31, 2018 | $11.68 B |
20.10%
|
Dec 29, 2017 | $9.72 B |
293.26%
|
Dec 30, 2016 | $2.47 B |
44.75%
|
Dec 31, 2015 | $1.71 B |
-66.36%
|
Dec 31, 2014 | $5.08 B |
133.53%
|
Dec 31, 2013 | $2.17 B |
10.95%
|
Dec 31, 2012 | $1.96 B |
30.42%
|
Dec 30, 2011 | $1.50 B |
35.79%
|
Dec 31, 2010 | $1.11 B |
76.40%
|
Dec 31, 2009 | $0.63 B |
494.74%
|
Dec 31, 2008 | $0.11 B |
-82.30%
|
Dec 31, 2007 | $0.60 B |
13.78%
|
Dec 29, 2006 | $0.52 B |
28.05%
|
Dec 30, 2005 | $0.41 B |
-42.30%
|
Dec 31, 2004 | $0.71 B |
-62.15%
|
Dec 31, 2003 | $1.87 B |
-6.56%
|
Dec 31, 2002 | $2.00 B |
5.56%
|
Dec 31, 2001 | $1.90 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Guardant Health
GH
|
$5.54 B |
0.000 M
|
![]() USA
|
![]() Illumina
ILMN
|
$11.80 B |
-0.000 M
|
![]() USA
|
![]() Natera
NTRA
|
$20.51 B |
-0.000 M
|
![]() USA
|
![]() Myriad Genetics
MYGN
|
$0.74 B |
-0.000 M
|
![]() USA
|
![]() NeoGenomics
NEO
|
$1.22 B |
0.000 M
|
![]() USA
|
![]() Hologic
HOLX
|
$13.06 B |
0.000 M
|
![]() USA
|
![]() Qiagen
QGEN
|
$8.98 B |
0.000 M
|
![]() Netherlands
|
![]() Thermo Fisher Scientific
TMO
|
$166.47 B |
0.002 M
|
![]() USA
|
![]() Agilent Technologies
A
|
$29.40 B |
-0.001 M
|
![]() USA
|
![]() Park Hotels & Resorts
PK
|
$1.96 B |
0.000 M
|
![]() USA
|
![]() Exact Sciences
EXAS
|
$8.11 B |
-0.000 M
|
![]() USA
|
![]() Becton Dickinson
BDX
|
$58.01 B |
-0.001 M
|
![]() USA
|
Market Cap | = | EXAS Stock Price | * | EXAS Shares Outstanding |
= | $43.67 | * | 0.19 B | |
= | $8.11 B |